AbbVie Inc.

ABBV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
8-K May 12, 2026 FORM 8-K
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
4 May 12, 2026
10-Q May 8, 2026 10-Q
SCHEDULE 13G Apr 29, 2026
8-K Apr 29, 2026 8-K
8-K Apr 3, 2026 8-K
4 Apr 2, 2026
4 Apr 2, 2026
4 Apr 2, 2026
SCHEDULE 13G/A Mar 26, 2026
ARS Mar 23, 2026 ARS
DEFA14A Mar 23, 2026 DEFA14A
DEF 14A Mar 23, 2026 DEF 14A
4/A Mar 11, 2026
PRE 14A Mar 9, 2026 PRE 14A
← Newer Page 2 of 61 · 1520 filings Older →